Project Grant 2404776
Award Date
9/1/24
Completion Date
8/31/25
Dollars Obligated
$275K
Federal Agency
National Science Foundation
Awardee
M3D, Inc. (YVW7EGYWXGM6)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48108, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Nanores LLC aims to develop a compact, multi-color super-resolution imaging system capable of visualizing molecular structures in thick biological tissues with nanoscale precision. The key products to be delivered include: An advanced fluorescence imaging system incorporating adaptive optics and spinning disk technology to enable 3D imaging of biological samples up...
The National Science Foundation (NSF) awarded a $650,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to the University of Illinois for the development of a bioinspired multispectral imaging sensor to support real-time intraoperative detection of cancer. The award aims to create a novel sensor that integrates perovskite nanocrystals and optical metasurfaces to simultaneously detect endogenous cancer biomarkers in the UV spectrum and exogenous markers...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop an innovative radiation imaging tool to support the advancement of targeted alpha cancer therapies. The $811,503 award to Qscint Imaging Solutions LLC, located in Tucson, AZ, will fund the refinement of an algorithm for real-time isotopic spectroscopy...
This $200,000 National Science Foundation (NSF) Engineering (CFDA 47.041) Project Grant award to Clarkson University will develop a novel near-infrared (NIR) mechanochemical biophotonic platform for deep-tissue biomedical imaging. The project aims to create a breakthrough technology that combines ultrasound waves and NIR light to enable high-resolution, 3D imaging of molecular and sub-cellular structures deep within the body. This approach seeks to address limitations of existing imaging...
The National Science Foundation (NSF) awarded a $295,000 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Theracea Pharma LC, a for-profit small business, to develop 18F-radiotracer kits for detection of biomarkers using positron emission tomography (PET). This SBIR Phase I project aims to create innovative diagnostic tools to enhance healthcare quality and improve patient outcomes, particularly in the field of oncology. The products will assist...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,990 to Scorpido Photonics aims to develop a prototype endoscope-based diagnostic system for rapid, non-invasive detection of microscopic tumors. The project integrates plasmonic nanobubble sensors into a medical device platform and standard endoscope to enable instant, optical detection of cancerous tissues during lung cancer diagnostic procedures. The key product is a...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Lightfinder Inc. aims to develop a silicon photonic optical coherence tomography (OCT) imager for pathology diagnostics. The primary objective is to create a high-performance, portable, and cost-effective imaging solution by integrating all optical components onto a single silicon chip. The research will address key technical challenges such as achieving high...
This Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $305,000 to Bired Imaging Inc. to develop an innovative breast cancer screening technology. The project aims to create a rapid, efficient, and contactless screening tool that can accurately detect breast cancer, even in dense breast tissue, using infrared imaging and physics-based AI algorithms. The goal is to improve early detection of...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Cerflux Inc. aims to develop a personalized cancer treatment screening platform. The project will establish guidelines for handling solid tumor biopsy samples, generate 3D bioprinted tumor models for validation, and demonstrate the platform's ability to match patients with the most effective cancer treatments before treatment begins. This innovative approach has the...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...